Related Experiment Video
Updated: Feb 8, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Diagnostic Algorithm for Cholesteryl Ester Storage Disease: Clinical Presentation in 19 Polish Patients
Patryk Lipiński1, Agnieszka Ługowska2, Ekaterina Y Zakharova3
1Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, The Children's Memorial Health Institute.
Cholesteryl ester storage disease (CESD), a form of lysosomal acid lipase deficiency (LAL-D), most commonly presents with hepatomegaly. Early recognition of hepatomegaly and dyslipidemia is key for timely CESD diagnosis.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Lysosomal acid lipase deficiency (LAL-D) is a rare inherited disorder of lipid metabolism.
- It presents as either severe Wolman disease or attenuated cholesteryl ester storage disease (CESD).
- CESD is characterized by lipid accumulation in various organs.
Purpose of the Study:
- To describe the clinical presentation of CESD, focusing on initial symptoms.
- To propose a diagnostic algorithm for CESD.
- To highlight the delay in diagnosis for CESD patients.
Main Methods:
- Observational, single-center study.
- Involved 19 Polish patients with late-onset LAL-D (CESD).
- Analysis of clinical presentation, diagnostic markers (LAL activity, LIPA gene mutations).
Main Results:
- Mean age of first symptoms: 4 years 6 months; mean age at diagnosis: 7 years 2 months.
- Hepatomegaly was the initial abnormality in all patients (100%).
- Dyslipidemia and elevated transaminases were common findings; diagnosis delayed by ~3 years.
Conclusions:
- Hepatomegaly is the most frequent presenting sign of CESD.
- Hepatomegaly combined with characteristic dyslipidemia (elevated total/LDL cholesterol, triglycerides; normal/low HDL) are key diagnostic findings.
- Early identification of these signs can improve diagnostic timelines.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies

